Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
16.70
1.60 (10.60%)
At close: Aug 14, 2025, 3:59 PM
16.60
-0.60%
Pre-market: Aug 15, 2025, 08:49 AM EDT

Beta Bionics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
78.02M 69.83M 65.12M 53.03M 39.42M 24.38M 11.44M 3.09M
Cost of Revenue
35.95M 32.17M 29.24M 23.77M 17.85M 10.89M 5.16M 1.87M
Gross Profit
42.08M 37.66M 35.89M 29.26M 21.57M 13.49M 6.29M 1.23M
Operating Income
-62.53M -54.44M -45.25M -40.58M -38.39M -26.6M -17.15M -8.78M
Interest Income
7.22M 5.21M 3.91M 2.96M 2.13M 1.14M n/a n/a
Pretax Income
-73.37M -70.96M -54.76M -55.5M -54.44M -39.98M -27.53M -8.68M
Net Income
-73.37M -70.96M -54.76M -55.5M -54.44M -39.98M -27.53M -8.68M
Selling & General & Admin
73.79M 63.8M 54.95M 48.41M 39.81M 26.3M 15.12M 6.15M
Research & Development
30.82M 28.3M 26.18M 21.43M 20.14M 13.79M 8.31M 3.85M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
104.61M 92.1M 81.14M 69.84M 59.96M 40.09M 23.44M 10.01M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
49.47M 42.83M 37.09M 31.9M 25.58M 16.61M 8.95M 3.33M
Cost & Expenses
140.55M 124.27M 110.38M 93.61M 77.81M 50.98M 28.59M 11.88M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
43.39M 30.71M 43.35M 6.26M 43.35M 30.5M 6.03M 5.06M
Shares Outstanding (Diluted)
43.39M 30.71M 43.35M 6.26M 43.35M 30.5M 6.03M 5.06M
EPS (Basic)
-3.29 -3.23 -2.71 -5.42 -5.58 -5.25 -4.84 -1.71
EPS (Diluted)
-3.29 -3.23 -2.71 -5.42 -5.58 -5.25 -4.84 -1.71
EBITDA
-66.16M -60.17M -51.03M -41.52M -39.32M -25.44M -16.55M -8.47M
EBIT
-64.6M -62.19M -53M -43.26M -41.06M -26.6M -17.15M -8.78M
Depreciation & Amortization
2.09M 2.02M 1.97M 1.74M 1.74M 1.17M 603.33K 311.33K